TickerFacts.

A business in context

AVTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-30 · 0002063957-26-000009

  2. 4 · Ownership change

    Report date 2026-09-30 · 0001707797-26-000017

  3. 4 · Ownership change

    Report date 2026-09-30 · 0001677036-26-000009

  4. 4 · Ownership change

    Report date 2026-09-16 · 0001810417-26-000023

  5. 4 · Ownership change

    Report date 2026-09-10 · 0001810417-26-000021

  6. 4 · Ownership change

    Report date 2026-08-28 · 0001918845-26-000031

  7. 4 · Ownership change

    Report date 2026-08-17 · 0001918845-26-000029

  8. 4 · Ownership change

    Report date 2026-08-17 · 0001810417-26-000019

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001534120-26-000049

  10. 8-K · Current report

    Report date 2026-08-06 · 0001534120-26-000048 · Items 2.02,9.01

  11. 8-K · Current report

    Report date 2026-06-23 · 0001534120-26-000044 · Items 5.02

  12. 8-K · Current report

    Report date 2026-06-16 · 0001534120-26-000042 · Items 8.01,9.01

  13. 8-K · Current report

    Report date 2026-06-11 · 0001534120-26-000040 · Items 3.02,3.03,5.02,5.03,9.01

  14. 8-K · Current report

    Report date 2026-06-02 · 0001534120-26-000036 · Items 5.02,5.07,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001534120-26-000033

  16. 8-K · Current report

    Report date 2026-05-13 · 0001534120-26-000032 · Items 2.02,9.01

  17. 8-K · Current report

    Report date 2026-05-05 · 0001104659-26-056482 · Items 1.01,2.02,7.01,9.01

  18. 8-K · Current report

    Report date 2026-05-05 · 0001534120-26-000028 · Items 8.01,9.01

  19. 8-K · Current report

    Report date 2026-04-26 · 0001534120-26-000026 · Items 1.01,7.01,9.01

  20. DEF 14A · Proxy statement

    Report date 2026-04-10 · 0001534120-26-000022

  21. 8-K · Current report

    Report date 2026-03-23 · 0001534120-26-000016 · Items 5.02

  22. 10-K · Annual report

    Report date 2025-12-31 · 0001534120-26-000011

  23. 8-K · Current report

    Report date 2026-03-23 · 0001534120-26-000010 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2026-01-12 · 0001534120-26-000003 · Items 2.02,8.01

  25. 8-K · Current report

    Report date 2025-12-02 · 0001534120-25-000022 · Items 8.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001534120-25-000018

  27. 8-K · Current report

    Report date 2025-11-06 · 0001534120-25-000017 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-10-29 · 0001534120-25-000013 · Items 8.01,9.01

  29. 8-K · Current report

    Report date 2025-10-10 · 0001534120-25-000011 · Items 8.01,9.01

  30. 8-K · Current report

    Report date 2025-09-29 · 0001534120-25-000009 · Items 5.02,8.01,9.01

  31. 8-K · Current report

    Report date 2025-09-16 · 0001534120-25-000005 · Items 5.02,9.01

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-038575

  33. 8-K · Current report

    Report date 2025-08-07 · 0001628280-25-038570 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-06-20 · 0001628280-25-032232 · Items 8.01,9.01

  35. 8-K · Current report

    Report date 2025-06-17 · 0001628280-25-032011 · Items 5.02,8.01,9.01

  36. 8-K · Current report

    Report date 2025-06-17 · 0001628280-25-031818 · Items 5.07

  37. 8-K · Current report

    Report date 2025-06-03 · 0001628280-25-029639 · Items 1.01,1.02,9.01

  38. 8-K · Current report

    Report date 2025-06-04 · 0001628280-25-029225 · Items 8.01,9.01

  39. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-024436

  40. 8-K · Current report

    Report date 2025-05-12 · 0001628280-25-024435 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 11 transaction rows11SGrant / award: 3 transaction rows3AExercise / conversion: 22 transaction rows22MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

36 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-16
2026-09-18
Sullivan Christopher Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock12394.09.88
2026-09-16
2026-09-18
Sullivan Christopher Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock12394.016.33
2026-09-16
2026-09-18
Sullivan Christopher Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
12394.00.0
2026-09-10
2026-09-11
Sullivan Christopher Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock10185.08.04
2026-09-10
2026-09-11
Sullivan Christopher Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock10185.017.62
2026-09-10
2026-09-11
Sullivan Christopher Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
10185.00.0
2026-08-28
2026-09-01
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock679.08.04
2026-08-28
2026-09-01
Doyle Mittie
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock679.020.0
2026-08-28
2026-09-01
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
679.00.0
2026-08-18
2026-08-19
Sullivan Christopher Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock31031.020.05
2026-08-18
2026-08-19
Sullivan Christopher Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock31031.09.88
2026-08-18
2026-08-19
Sullivan Christopher Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
31031.00.0
2026-08-17
2026-08-19
Doyle Mittie
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1000.020.0
2026-08-17
2026-08-19
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock1000.012.65
2026-08-17
2026-08-19
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
1000.00.0
2026-08-17
2026-08-19
Sullivan Christopher Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3749.019.94
2026-08-17
2026-08-19
Sullivan Christopher Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock37945.019.85
2026-08-17
2026-08-19
Sullivan Christopher Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock2876.09.88
2026-08-17
2026-08-19
Sullivan Christopher Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock37945.09.88
2026-08-17
2026-08-19
Sullivan Christopher Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
37945.00.0
2026-08-17
2026-08-19
Sullivan Christopher Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
2876.00.0
2026-08-11
2026-08-12
Riley JenniferS · Sale
Disposed
Common Stock2655.019.59
2026-08-10
2026-08-12
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock679.08.04
2026-08-10
2026-08-12
Doyle Mittie
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock679.020.0
2026-08-10
2026-08-12
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
679.00.0
2026-07-27
2026-07-29
Doyle Mittie
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1000.020.0
2026-07-27
2026-07-29
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock1000.012.65
2026-07-27
2026-07-29
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
1000.00.0
2026-06-30
2026-07-02
Philip Ron MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
69.015.04
2026-06-30
2026-07-02
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock2875.012.65
2026-06-30
2026-07-02
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock1779.08.04
2026-06-30
2026-07-02
Doyle Mittie
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4654.020.0
2026-06-30
2026-07-02
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
1779.00.0
2026-06-30
2026-07-02
Doyle Mittie
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
2875.00.0
2026-06-30
2026-07-02
Jain RitaA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1080.015.04
2026-06-30
2026-07-02
Lind Kevin RobertA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1105.015.04

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001534120Avalo Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • Cerecor Inc. · former SEC name · 2012-04-04 to 2021-08-18

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$441.0K$473.7K
2023-12-31$1.92M$2.13M
2022-12-31$18.05M$20.78M
2021-12-31$5.40M$6.71M
2020-12-31$6.70M$8.72M
2019-12-31$6.75M$8.90M
2018-12-31$7.03M$9.43M
2017-12-31$27.81M$38.23M

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗